0000899243-21-024427.txt : 20210617
0000899243-21-024427.hdr.sgml : 20210617
20210617163325
ACCESSION NUMBER: 0000899243-21-024427
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210616
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krieg Arthur M
CENTRAL INDEX KEY: 0001335659
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39425
FILM NUMBER: 211025176
MAIL ADDRESS:
STREET 1: C/O CHECKMATE PHARMACEUTICALS, INC.
STREET 2: 245 MAIN STREET, 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Checkmate Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001651431
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 364813934
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 MAIN STREET, 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 978-503-2124
MAIL ADDRESS:
STREET 1: 245 MAIN STREET, 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-16
0
0001651431
Checkmate Pharmaceuticals, Inc.
CMPI
0001335659
Krieg Arthur M
C/O CHECKMATE PHARMACEUTICALS, INC.
245 MAIN STREET, 2ND FLOOR
CAMBRIDGE
MA
02142
0
1
0
0
Chief Scientific Officer
Common Stock
2021-06-16
4
P
0
3578
6.18
A
808510
D
The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions, at prices ranging from $6.17 to $6.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Exhibit 24 - Power of Attorney
/s/ Katherine Eade, attorney-in-fact
2021-06-17